Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL)

Journal of Neuro-Oncology

Volumn 43, Issue 3, 1999, Pages 241-247

  Nelson, Diana Furst ^a  

^a MAYO CLINIC   (United States)

Author keywords

Brain lymphoma; Combined modality therapy; Non Hodgkin's lymphoma of brain; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; VINCRISTINE;

BRAIN LYMPHOMA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; HUMAN; INTRATHECAL DRUG ADMINISTRATION; RADIATION DOSE; REVIEW; TREATMENT OUTCOME;

BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; HUMANS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; RADIOTHERAPY DOSAGE;

EID: 0032832421     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006206602918     Document Type: Review

References (39)

1. Eby NL, Grufferman S, Flannelly CM, Schold SC, Vogel FS, Burger PC: Increasing incidence of primary brain lymphoma in the U.S. Cancer 62: 2461-2465, 1988
2. Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, Kerman UD, Thomson JW, Murray KJ: Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 23: 9-17, 1992
3. Schultz C, Scott C, Sherman W, Donahue B, Fields J, Murray K, Fisher B, Abrams R, Meis-Kindblom: Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of Radiation Therapy Oncology Group Protocol 88-06. J Clin Oncol 14: 556-564, 1996
4. O'Neill BP, O'Fallon JR, Earle JD, Colgan JP, Brown LD, Krigel RL: Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? Int Radiat Oncol Biol Phys 33: 663-673, 1995
5. Hayakawa T, Takakura K, Abe H, Yoshimoto T, Tanaka R, Sugita K, Kikuchi H, Uozumi T, Hori T, Fukui H, Ushio Y, Nomura K, Matsutani M, Mohri N, Kumanishi T, Aozasa K, Nagashima K: Primary central nervous system lymphoma in Japan: a retrospective, cooperative study by CNS-Lymphoma Study Group in Japan. J Neuro-Oncol 19: 197-215, 1994
6. Glass J, Gruber ML, Cher L, Hockberg FH: Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 81: 188-195, 1994
7. Bessell EM, Graus F, Punt JAG, Firth JL, Hope DT, Moloney AJ, Lopez-Guillermo A, Villa S: Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. J Clin Oncol 14: 945-954, 1996
8. Pollack IF, Lunsford LD, Flickinger JC, Dameshe K: Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63: 939-947, 1989
9. Jellinger K, Radaskiewicz TH, Slowik F: Primary malignant lymphomas of the central nervous system in man. Acta Neuropath (Berlin) (Suppl VI): 95-102, 1975
10. Henry JM, Heffner RR, Dillard SH et al.: Primary malignant lymphomas of the central nervous system. Cancer 34: 1293, 1974
11. Gonzalez D, Schuster-Uitterhoeve ALJ: Primary non-Hodgkin's lymphoma of the central nervous system. Results of radiotherapy in 15 cases. Cancer 51: 2048-2052, 1983
12. Laperriere NJ, Cerezo L, Milosevic MF, Shun Wong C, Patterson B, Panzarella T: Primary lymphoma of brain: results of management of a modern cohort with radiation therapy. Radiother Oncol 43: 247-252, 1997
13. Littman P, Wang CC: Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases. Cancer 35: 1412-1420, 1975
14. Letendre L, Banks PM, Reese DF, Miller RH, Scanlon PW, Kiely JM: Primary lymphoma of the central nervous system. Cancer 49: 939-943, 1982
15. Mendenhall NP, Thar TL, Agrr OF: Primary lymphoma of the central nervous system. Cancer 52: 1993-2000, 1983
16. Murray K, Kun L, Cox J: Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. J Neurosurg 65: 600-607, 1986
17. Rampen FHJ, van Andel JG, Sizoo W, van Unnik JAM: Radiation therapy in primary non-Hodgkin's lymphomas of the CNS. Eur J Cancer 16: 177-184, 1980
18. Berry MP, Simpson WJ: Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys 7: 755-759, 1981
19. Sagerman RH, Cassady JR, Chang CH: Radiation therapy for intracranial lymphoma. Radiology 88: 552-554, 1967
20. Sagerman RH, Collier CH, King GA: Radiation therapy of microgliomas. Radiology 149: 567-570, 1983
21. Blay JY, Bouhour D, Carrie C, Bouffet F, Brunat-Mentigny M, Philip T, Biron P: The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression. Blood 86: 2922-2929, 1995
22. DeAngelis LM, Yahalom J, Thaler HT, Kher U: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10: 635-643, 1992
23. Newalt EA, Goldman DL, Dahlborg SA: Primary CNS lymphoma treated with osmotic blood brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9: 1580-1590, 1991
24. Chen MG, Prosnitz LR, Gonzalez-Serva A, Fischer DB: Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma. Cancer 43: 1245-1254, 1979
25. Fraser RW, Chism SF, Stern R, Fu KK, Buschke F: Clinical course of early extranodal non-Hodgkin's lymphomas. Int J Radiat Oncol Biol Phys 11: 177-183, 1985
26. Horiuchi J, Okuyama T, Matsubara S, Shibuya H, Suzuki S, Kamiyama R: Extranodal non-Hodgkin's lymphoma in the head and neck. Irradiation and clinical course. Acta Radiol Oncol 21: 393-399, 1982
27. Jacobs C, Hoppe RT: Non-Hodgkin's lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phys 11: 357-364, 1985
28. Mill WB, Lee FA, Franssila KO: Radiation therapy treatment of stage I and II extranodal non-Hodgkin's lymphoma of the head and neck. Cancer 45: 653-661, 1980
29. Shirato H, Tsujii H, Arimoto T, Miiyamoto M, Azumi N, Nojima T, Watanbe S, Illie G: Early stage head and neck non-Hodgkin's lymphoma. The effect of tumor burden on prognosis. Cancer 58: 2312-2319, 1986
30. Teshima T, Chatani M, Hata K, Inoue T, Miyahara H, Sato T, Shibata H, Kusakabe H, Tateishi R, Suzuki T: Radiation therapy for primary non-Hodgkin's lymphoma of the head and neck in stage I-II. Strahlenther Onkol 162: 478-483, 1986
31. Wulfrank D, Speelman T, Pauwels C, Roels H, DeSchryver A: Extranodal non-Hodgkin's lymphoma of the head and neck. Radiother Oncol 8: 199-207, 1987
32. Fuks Z, Kaplan HS: Recurrence rates folowing radiation therapy of nodular and diffuse malignant lymphomas. Radiology 108: 675-684, 1973
33. Cox JD, Koehl RH, Turner WM, King FM: Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin's malignant lymphoma). Radiology 112: 179-185, 1974.
34. Bush RS, Gospodarowicz M: The place of radiation therapy in the management of patients with localized non-Hodgkin's lymphoma. In: Rosen SA, Kaplan HS (eds) Malignant Lymphomas. Academic Press, Orlando, pp. 485-502, 1982.
35. Loeffler JS, Ervin TJ, Mauch P: Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 3: 490-494, 1985
36. Hochberg FH: Chemotherapy alone in the treatment of PCNSL, presented at the International Primary Central Nervous System Lymphoma Meeting, Tubingen, Germany, 1997 (published this issue)
37. De Angelis LM: Radiochemotherapy in the treatment of PCNSL, presented at the International Primary Central Nervous System Lymphoma Meeting, Tubingen, Germany, 1997 (published this issue)
38. Cox JD, Koehl RH, Turner WM, King FM: Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin's malignant lymphoma). Radiology 112: 179-185, 1974.
39. Ott RJ, Brada M, Flower MA, Babich JW, Cherry SR, Deehan BJ: Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 27: 1356-1361, 1991